technetium tc 99m sestamibi has been researched along with Sclerosis, Systemic in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YW; Ding, HJ; Ho, ST; Kao, A; Lin, CC; Wang, JJ | 1 |
Belloli, L; Carlo-Stella, N; Chiti, A; Ciocia, G; Marasini, B; Massarotti, M | 1 |
Park, CH; Richard, MD | 1 |
Cox, D; Earle, L; Richard, M; Varga, J | 1 |
Banci, M; Barbieri, C; Boccabella, GL; DeSantis, M; Ierardi, M; Morelli, S; Rinaldi, E; Scopinaro, F; Tiberio, NS | 1 |
Higuchi, T; Kawano, M; Nakajima, K; Nishijima, C; Sato, S; Takehara, K; Taki, J; Tonami, N | 1 |
1 trial(s) available for technetium tc 99m sestamibi and Sclerosis, Systemic
Article | Year |
---|---|
Usefulness of technetium-99m sestamibi myocardial perfusion SPECT in detection of cardiovascular involvement in patients with systemic lupus erythematosus or systemic sclerosis.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Electrocardiography; Female; Heart; Humans; Lupus Erythematosus, Systemic; Radiopharmaceuticals; Risk Factors; Scleroderma, Systemic; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2003 |
5 other study(ies) available for technetium tc 99m sestamibi and Sclerosis, Systemic
Article | Year |
---|---|
Myocardial involvement in systemic sclerosis.
Topics: Adult; Aged; Cardiomyopathies; Female; Humans; Male; Middle Aged; Radiopharmaceuticals; Risk Factors; Scleroderma, Systemic; Severity of Illness Index; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2008 |
Tc-99m MIBI uptake secondary to pulmonary interstitial fibrosis in progressive systemic sclerosis.
Topics: Female; Heart; Humans; Lung; Middle Aged; Pulmonary Fibrosis; Scleroderma, Systemic; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1995 |
Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis.
Topics: Coronary Disease; Dyspnea; Endothelium, Vascular; Female; Fibroblasts; Heart; Humans; Injections, Intravenous; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Mitochondria; Pilot Projects; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Radionuclide Imaging; Radiopharmaceuticals; Scleroderma, Systemic; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Total Lung Capacity; Vital Capacity | 1998 |
99mTc SESTAMIBI scintigraphic evaluation of skeletal muscle disease in patients with systemic sclerosis: diagnostic reliability and comparison with cardiac function and perfusion.
Topics: Cardiomyopathies; Case-Control Studies; Female; Heart; Humans; Male; Middle Aged; Muscle, Skeletal; Muscular Diseases; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Scleroderma, Systemic; Technetium Tc 99m Pentetate; Technetium Tc 99m Sestamibi | 1998 |
Diastolic dysfunction in patients with systemic sclerosis detected by gated myocardial perfusion SPECT: an early sign of cardiac involvement.
Topics: Coronary Circulation; Diastole; Female; Heart Diseases; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Radiopharmaceuticals; Scleroderma, Systemic; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2001 |